Johnson & Johnson vs Arcus Biosciences, Inc. — Stock Comparison

JNJ
Johnson & Johnson
$227.19
▼ 1.16%
vs
RCUS
Arcus Biosciences, Inc.
$25.68
▲ 0.71%
Q·Score Winner
Johnson & Johnson
JNJ7.1/10vs 5.7/10

Q·Score Breakdown

7.1
Bullish
Overall
5.7
Neutral
9.3
Quality
0.2
6.5
Health
9.2
5.1
Growth
7.7
7.3
Valuation
5.7
6.5
Sentiment
7.2
JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

RCUS

Clean balance sheet with low leverage (0.3× debt-to-equity).

currently unprofitable (-143% margin).

Analyst Consensus

BUY
Target $252.42 (+11.1%)
24 analysts
BUY
Target $34.00 (+32.4%)
10 analysts

Fundamentals

JNJ
RCUS
26.3×
Trailing P/E
17.9×
Forward P/E
-7.3×
21.8%
Profit Margin
-142.9%
68.0%
Gross Margin
-111.7%
26.4%
ROE
-63.3%
9.9%
Revenue Growth
26.9%
-52.9%
Earnings Growth
0.33
Beta
0.86
Price / Book
$546.9B
Market Cap
$3.2B
$146 – $252
52-Week Range
$7 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →